Skip to main content
Signal8

AH Bio Fund IV, L.P.

SEC insider (Form 3/4/5 filer). CIK 0001889476. 10% Owner at Braveheart Bio, Inc. (BRVE). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in MENLO PARK, CA.

Companies AH Bio Fund IV, L.P. has filed insider reports for

  • Braveheart Bio, Inc. (BRVE): 10% Owner
AH Bio Fund IV, L.P. profile photo

AH Bio Fund IV, L.P.

CIK: 0001889476

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Braveheart Bio, Inc. logo
BRVE

Braveheart Bio, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Braveheart Bio, Inc. logo
    BRVE

    Braveheart Bio, Inc.

    Aug 7, 2026
    Conversion
    Indirect
    9.1M shares-
  • Braveheart Bio, Inc. logo
    BRVE

    Braveheart Bio, Inc.

    Aug 7, 2026
    Purchase
    Indirect
    1.1M shares at avg. $18.00$19.8M

1-2 of 2